|Articles|November 9, 2017

Elligo Health Research and PatientLink Form a Partnership

Elligo Health Research is now connecting physicians and patients to treatment options through a new partnership with PatientLink Enterprises. In order to do this, Elligo's "Goes DirectTM" approach will be best implemented to benefit customers who are ready to bring clinical studies to their practice and will allow for physicians to obtain the resources that they need for research.

Read the full release here.

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!

Related Content

© photon_photo - © photon_photo - stock.adobe.com

Elligo Health Research and PatientLink Form a Partnership

Newsletter

Related Content

Drug Repurposing Through AI-Driven In-Silico Clinical Trials

ACT Brief: CNS Trial Expansion, Vaccine Policy Debate, and New Leadership at FDA

Obesity Trials: Scaling Operations for High-Demand Therapeutics

Former FDA Commissioners Warn New Vaccine Policies Could Undermine Longstanding Regulatory Framework

ACT Brief: Targeted Trial Growth, Site Startup Strains, and Leadership Shake-Up at FDA

Trending on Applied Clinical Trials Online

How the FDA’s CNPV Program Is Reshaping Trial Operations and Accelerated Review Strategies

Former FDA Commissioners Warn New Vaccine Policies Could Undermine Longstanding Regulatory Framework

ACT Brief: Targeted Trial Growth, Site Startup Strains, and Leadership Shake-Up at FDA

Voyxact Lands FDA Accelerated Approval Following Positive Results in Phase III VISIONARY Trial

New ICON Survey Shows Sites Face Growing Delays and Communication Gaps During Study Startup